Kory James Wentworth - 03 Apr 2025 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Chief Financial Officer
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Issuer symbol
TRDA
Transactions as of
03 Apr 2025
Net transactions value
+$23,381
Form type
4
Filing time
04 Apr 2025, 16:34:29 UTC
Previous filing
19 Mar 2025
Next filing
04 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRDA Common Stock Options Exercise $23,381 +11,134 +10% $2.10 120,670 03 Apr 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRDA Stock Option (Right to Buy) Options Exercise $0 -11,134 -36% $0.000000 20,023 03 Apr 2025 Common Stock 11,134 $2.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option fully vested on November 16, 2024.